Literature DB >> 18608866

Dasatinib-induced acute hepatitis.

A Bonvin, A Mesnil, F E Nicolini, L Cotte, M Michallet, J Descotes, T Vial.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18608866     DOI： 10.1080/10428190802136384

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  9 in total

Review 1.  Metabolism considerations for kinase inhibitors in cancer treatment.

Authors:  Derek R Duckett; Michael D Cameron
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-10       Impact factor: 4.481

2.  Characterization of dasatinib and its structural analogs as CYP3A4 mechanism-based inactivators and the proposed bioactivation pathways.

Authors:  Xiaohai Li; Yuanjun He; Claudia H Ruiz; Marcel Koenig; Michael D Cameron; Tomas Vojkovsky
Journal:  Drug Metab Dispos       Date:  2009-03-12       Impact factor: 3.922

3.  Metabolism and bioactivation of famitinib, a novel inhibitor of receptor tyrosine kinase, in cancer patients.

Authors:  Cen Xie; Jialan Zhou; Zitao Guo; Xingxing Diao; Zhiwei Gao; Dafang Zhong; Haoyuan Jiang; Lijia Zhang; Xiaoyan Chen
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

4.  Autophagy protects against dasatinib-induced hepatotoxicity via p38 signaling.

Authors:  Xiaochun Yang; Jincheng Wang; Jiabin Dai; Jinjin Shao; Jian Ma; Chao Chen; Shenglin Ma; Qiaojun He; Peihua Luo; Bo Yang
Journal:  Oncotarget       Date:  2015-03-20

5.  Learning important features from multi-view data to predict drug side effects.

Authors:  Xujun Liang; Pengfei Zhang; Jun Li; Ying Fu; Lingzhi Qu; Yongheng Chen; Zhuchu Chen
Journal:  J Cheminform       Date:  2019-12-16       Impact factor: 5.514

Review 6.  A narrative review on adverse effects of dasatinib with a focus on pharmacotherapy of dasatinib-induced pulmonary toxicities.

Authors:  Zahra Nekoukar; Minoo Moghimi; Ebrahim Salehifar
Journal:  Blood Res       Date:  2021-12-31

Review 7.  Potential role of drug metabolizing enzymes in chemotherapy-induced gastrointestinal toxicity and hepatotoxicity.

Authors:  Gabriel Tao; Junqing Huang; Bhagavatula Moorthy; Cathryn Wang; Ming Hu; Song Gao; Romi Ghose
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-09-02       Impact factor: 4.481

8.  Dasatinib-Induced CMV Hepatitis in an Immunocompetent Patient: A Rare Complication of a Common Drug.

Authors:  Fidencio Davalos; Benjamin Chaucer; Wahib Zafar; Shamim Salman; Jay Nfonoyim
Journal:  Transl Oncol       Date:  2016-06       Impact factor: 4.243

9.  Comparison of Hepatotoxicity Associated With New BCR-ABL Tyrosine Kinase Inhibitors vs Imatinib Among Patients With Chronic Myeloid Leukemia: A Systematic Review and Meta-analysis.

Authors:  Zhe Wang; Xiaoyu Wang; Zhen Wang; Yuyi Feng; Yaqin Jia; Lili Jiang; Yangliu Xia; Jun Cao; Yong Liu
Journal:  JAMA Netw Open       Date:  2021-07-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.